In line with the results of the HFHC-induced NASH model, Laptm5 deficiency evidently promoted MCD diet-induced liver metabolic disorders and liver injury (Supplementary Fig. 6a–g). Here, LAPTM5 is linked to metabolic dysfunction-associated steatohepatitis.